Texas · CDMO Insurance Practice
A Texas-based practice for Texas pharmaceutical and medical device contract manufacturers.
Texas has approximately 80-150 contract manufacturers in the pharmaceutical, medical device, and specialty bulk product segments — concentrated in DFW (pharma packaging and medical device manufacturing), Houston (biologics, diagnostics, and TMC-adjacent operations), and Austin (smaller medtech and biotech contract operations).
The Texas-specific factors that show up in our work most often:
- Workers compensation non-subscriber status. Texas is the only state where workers comp is technically optional. Most pharma sponsor MSAs require WC regardless. We help non-subscribers evaluate the path back into the WC system or build the alternate plan that satisfies the sponsor requirement.
- Property exposure on the coast. Houston and the Gulf Coast face named-storm and hurricane exposure that drives material differences in property pricing and sublimits versus inland Texas.
- Texas's plaintiff-friendly products tort environment. Texas is generally favorable relative to California or New York, but specific venues (some South Texas counties) have heavier tort histories that show up in carrier underwriting commentary.
- Texas Department of Insurance carrier admittance. Some specialty surplus-lines placements common in life sciences require an explicit non-admitted-market acknowledgment in Texas. We handle the documentation; worth knowing it exists.
Geographic depth
Dallas-Fort Worth
Frisco, Plano, Lewisville, Fort Worth, and the I-35 corridor. Pharma packaging, medical device, and specialty bulk.
Read more →Houston / TMC
Texas Medical Center and surrounding markets. Biologics, devices, diagnostics, cell-and-gene operations.
Read more →Austin & Central Texas
Smaller medtech and biotech contract manufacturing. Programs placed remotely with periodic on-site visits as needed.
Read more →Free MSA review
A specialist will reach out by the end of the day.
Statewide questions
Common questions from Texas CDMO operators
How many pharmaceutical CDMOs operate in Texas?
+
Roughly 150 to 200 contract manufacturers across the state when counting pharma, medical device, and biotech CDMOs. Concentrations are in DFW, Houston (TMC), Austin, San Antonio, and the Texas Medical Triangle corridor.
Are there state-specific requirements for Texas pharma CDMOs?
+
Texas requires Texas-licensed insurance carriers for certain categories and has its own anti-indemnity statute provisions that affect how MSA indemnity interacts with insurance. Most national pharma insurance programs are written compliantly, but a Texas-licensed counsel review is worth the cost on first MSA negotiation with a new sponsor.
What is the typical pharma CDMO insurance budget as a percentage of revenue?
+
For Texas CDMOs in the $5M-$50M revenue range, total commercial insurance cost typically runs 0.5% to 1.5% of revenue. Higher-risk product categories (sterile injectables, biologics, oncology) push that to 2% or more. The Decoder produces a more specific estimate after seeing the sponsor MSA requirements.
Can a single program cover multiple Texas manufacturing sites?
+
Yes — multi-location programs are standard. Be careful with two things: aggregate limits per location (some sponsor MSAs require per-location aggregates that a shared program does not satisfy), and property/business-interruption written separately per site so a claim at one site does not exhaust the others' limits.
How do FDA inspection findings affect insurance renewals?
+
FDA Form 483 observations are not automatically renewal-relevant, but Warning Letters and Consent Decrees almost always trigger underwriting attention. Carriers may require remediation timelines, third-party audits, or limit reductions until findings clear. Renewal terms can change materially mid-cycle if a Warning Letter lands.
Do Texas CDMOs need cyber coverage at the same limits as other states?
+
Yes — cyber requirements come from sponsor MSAs and federal regulation (HIPAA, 21 CFR Part 11), not state law. Texas has its own breach-notification statute that is reasonably aligned with the federal HIPAA notification rules, so practical coverage requirements track other states closely.